Top compounds associated with response to EIF2D


Feature Type Standardized
Nominal ANOVA
mRNA BX-912 GDSC1000 pan-cancer AAC -0.091 0.004
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.11 0.004
mRNA clofarabine CTRPv2 pan-cancer AAC 0.089 0.004
mRNA UNC0321 CTRPv2 pan-cancer AAC -0.11 0.005
mRNA YM201636 GDSC1000 pan-cancer AAC -0.092 0.005
mRNA Nutlin-3 CTRPv2 pan-cancer AAC 0.1 0.005
mRNA Gemcitabine gCSI pan-cancer AAC 0.16 0.005
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.006
mRNA Cyclopamine FIMM pan-cancer AAC -0.39 0.006
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.006
Download CSV